stock rating BTIG Initiates Coverage of Berkeley Lights With Buy Rating BTIG said that the firm is emerging as a leader in enabling the characterization of live cells to accelerate development of biotherapeutics and other products. JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Analysts estimated the total addressable market for the San Diego-based next-generation sequencing firm at between $44 billion and $50 billion. Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector. William Blair Initiates Coverage of 10x Genomics With Outperform Rating Analysts for the investment bank, which co-managed a recent 10x stock offering, said the company could "redefine the way biological analysis is performed." Evercore ISI Downgrades Twist Bioscience to In-Line Rating The investment bank said that while Twist's biopharma and DNA-based data storage businesses offer upside, the timelines for generating revenues are unclear. Dec 16, 2020 Piper Sandler Raises Rating on Oncocyte to Overweight Nov 2, 2020 Pacific Biosciences Q3 Revenues Fall 13 Percent Oct 20, 2020 SVB Leerink Initiates Coverage of Twist Bioscience With Market Perform Rating Oct 2, 2020 Pacific Biosciences Upgraded to Overweight by JP Morgan Sep 21, 2020 JP Morgan Downgrades Illumina to Neutral on Grail Deal Aug 19, 2020 Oppenheimer Initiates Coverage of Fulgent Genetics With Outperform Rating Jul 14, 2020 BTIG, Canaccord Genuity Initiate Coverage of Genetron with Buy Ratings Apr 2, 2020 Evercore ISI Initiates Coverage of Exact Sciences at Outperform Feb 3, 2020 Illumina Stock Drags GenomeWeb Index Down in January Jan 2, 2020 Evercore ISI Upgrades PerkinElmer, Downgrades Hologic Dec 2, 2019 Investment Banks Initiate Coverage of Centogene With Bullish Outlooks Oct 7, 2019 Cowen, JP Morgan, Evercore ISI, Bank of America Initiate Coverage of 10x Genomics Jun 11, 2019 Piper Jaffray Initiates Coverage of Danaher, Agilent Feb 15, 2018 Foundation Medicine Coverage Initiated by Cowen Dec 13, 2017 JP Morgan Downgrades Genomic Health to Underweight Oct 4, 2016 First Analysis Initiates Coverage of NeoGenomics at Overweight Jan 5, 2016 GenomeWeb Index Rises 5 Percent in 2015, Led by PacBio; Fluidigm Leads Decliners Dec 14, 2015 Raymond James Downgrades Quidel's Stock Sep 2, 2015 Barclays Initiates Coverage on Genomic Health, Quidel, Cepheid; Upgrades Hologic May 21, 2015 Investment Banks Downgrade Bruker on Resignation of CFO Load More Breaking News Lander, Collins Offer Vision for Advanced Research Projects Agency for Health LetsGetChecked Partners With California Department of Public Health for COVID-19 Sequencing BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M The Scan Could Cost Billions NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars. Not Quite Sent The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post. DTC Regulation Proposals A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports. PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.